{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:11:54Z","timestamp":1790997114139,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K23DK118198"],"award-info":[{"award-number":["K23DK118198"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K23HL150236"],"award-info":[{"award-number":["K23HL150236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K24DK092291"],"award-info":[{"award-number":["K24DK092291"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chronic Kidney Disease Biomarker Consortium","award":["U01DK103225"],"award-info":[{"award-number":["U01DK103225"]}]},{"name":"Chronic Kidney Disease Biomarker Consortium","award":["U01DK106965"],"award-info":[{"award-number":["U01DK106965"]}]},{"name":"Chronic Kidney Disease Biomarker Consortium","award":["U01DK103225"],"award-info":[{"award-number":["U01DK103225"]}]},{"name":"Chronic Kidney Disease Biomarker Consortium","award":["U01DK060990"],"award-info":[{"award-number":["U01DK060990"]}]},{"name":"Chronic Kidney Disease Biomarker Consortium","award":["R01DK104730"],"award-info":[{"award-number":["R01DK104730"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) is associated with atherosclerotic cardiovascular disease (ASCVD) risk, especially among those with diabetes. Altered metabolism of solutes that accumulate in CKD [asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and trimethylamine N-oxide (TMAO)] may reflect pathways linking CKD with ASCVD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This case\u2013cohort study included Chronic Renal Insufficiency Cohort participants with baseline diabetes, estimated glomerular filtration rate &amp;lt;60\u00a0mL\/min\/1.73 m2, and without prior history for each outcome. The primary outcome was incident ASCVD (time to first myocardial infarction, stroke or peripheral artery disease event) and secondary outcome was incident heart failure. The subcohort comprised randomly selected participants meeting entry criteria. Plasma and urine ADMA, SDMA and TMAO concentrations were determined by liquid chromatography\u2013tandem mass spectrometry. Associations of uremic solute plasma concentrations and urinary fractional excretions with outcomes were evaluated by weighted multivariable Cox regression models, adjusted for confounding covariables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Higher plasma ADMA concentrations (per standard deviation) were associated with ASCVD risk [hazard ratio (HR) 1.30, 95% confidence interval (CI) 1.01\u20131.68]. Lower fractional excretion of ADMA (per standard deviation) was associated with ASCVD risk (HR 1.42, 95% CI 1.07\u20131.89). The lowest quartile of ADMA fractional excretion was associated with greater ASCVD risk (HR 2.25, 95% CI 1.08\u20134.69) compared with the highest quartile. Plasma SDMA and TMAO concentration and fractional excretion were not associated with ASCVD. Neither plasma nor fractional excretion of ADMA, SDMA and TMAO were associated with incident heart failure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These data suggest that decreased kidney excretion of ADMA leads to increased plasma concentrations and ASCVD risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfad103","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T03:25:55Z","timestamp":1685071555000},"page":"2809-2815","source":"Crossref","is-referenced-by-count":19,"title":["Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study"],"prefix":"10.1093","volume":"38","author":[{"given":"Sarah J","family":"Schrauben","sequence":"first","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, Center for Clinical Epidemiology and Biostatistics at the Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA , USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hima","family":"Sapa","sequence":"additional","affiliation":[{"name":"CSL Seqirus , Holly Springs, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Hyre","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA , USA"},{"name":"Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University , New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Shlipak","sequence":"additional","affiliation":[{"name":"Kidney Health Research Collaborative, San Francisco Veterans Affairs Healthcare System , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-yuan","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, University of California, San Francisco , San Francisco, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Shafi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Houston Methodist Hospital , Houston, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupal","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology and Hypertension, Northwestern University , Chicago, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenat","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wayne State University , Detroit, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Illinois at Chicago , Chicago, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Charleston","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Nephrology, Johns Hopkins School of Medicine , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8286-9652","authenticated-orcid":false,"given":"Jiang","family":"He","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tulane University School of Medicine , New Orleans, LA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H","family":"Ix","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology-Hypertension, UC San Diego School of Medicine , San Diego, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pandurango","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, University of Michigan , Ann Arbor, MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Townsend","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, Center for Clinical Epidemiology and Biostatistics at the Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L","family":"Kimmel","sequence":"additional","affiliation":[{"name":"Division of Kidney, Urologic & Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases , Bethesda, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S","family":"Vasan","sequence":"additional","affiliation":[{"name":"The University of Texas School of Public Health San Antonio , San Antonio, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold I","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, Center for Clinical Epidemiology and Biostatistics at the Perelman School of Medicine at the University of Pennsylvania , Philadelphia, PA , USA"},{"name":"Patient-Centered Outcomes Research Institute , Washington, DC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse C","family":"Seegmiller","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Minnesota , Minneapolis, MN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Brunengraber","sequence":"additional","affiliation":[{"name":"Departments of Nutrition and Biochemistry, Case Western University School of Medicine , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H","family":"Hostetter","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, University of North Carolina , Chapel Hill, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3503-2208","authenticated-orcid":false,"given":"Jeffrey R","family":"Schelling","sequence":"additional","affiliation":[{"name":"Departments of Physiology & Biophysics and Medicine, Case Western Reserve University School of Medicine , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CKD Biomarkers Consortium and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallabh O","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie L","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L","family":"Unruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"2023120101463943300_bib1","doi-asserted-by":"crossref","first-page":"e0168117","DOI":"10.1371\/journal.pone.0168117","article-title":"Uremic solutes in chronic kidney disease and their role in progression","volume":"11","author":"van den Brand","year":"2016","journal-title":"PLoS One"},{"key":"2023120101463943300_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1681\/ASN.V1081815","article-title":"Pathophysiologic effects of uremic retention solutes","volume":"10","author":"Vanholder","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2023120101463943300_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bbrc.2011.11.144","article-title":"Upregulation of BAD, a pro-apoptoic protein of the BCL2 family, in vascular smooth muscle cells exposed ot uremic conditions","volume":"417","author":"Trecherel","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"2023120101463943300_bib4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2023120101463943300_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/toxins10010033","article-title":"Biochemical and clinical impact of organic uremic rention solutes: a comprehensive update","volume":"10","author":"Vanholder","year":"2018","journal-title":"Toxins"},{"key":"2023120101463943300_bib6","doi-asserted-by":"crossref","first-page":"e0135657","DOI":"10.1371\/journal.pone.0135657","article-title":"An enlarged profile of uremic solutes","volume":"10","author":"Tanaka","year":"2015","journal-title":"PLoS One"},{"key":"2023120101463943300_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"2023120101463943300_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Wilson Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"2023120101463943300_bib9","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2174\/138161208786071326","article-title":"Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications","volume":"14","author":"Yamagishi","year":"2008","journal-title":"Curr Pharm Des"},{"key":"2023120101463943300_bib10","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of assymetrical dimethylarginine and mortality in patients with end-stage renal disease","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet North Am Ed"},{"key":"2023120101463943300_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/clinchem.2006.076711","article-title":"Asymmetrical dimethylarginine independentaly predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health Study)","volume":"53","author":"Meinitzer","year":"2007","journal-title":"Clin Chem"},{"key":"2023120101463943300_bib12","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet North Am Ed"},{"key":"2023120101463943300_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metbaolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"2023120101463943300_bib14","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","article-title":"The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods","volume":"14","author":"Feldman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2023120101463943300_bib15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023120101463943300_bib16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.ajkd.2022.02.016","article-title":"Association of uremic solutes with cardiovascular death in diabetic kidney disease","volume":"80","author":"Sapa","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2023120101463943300_bib17","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"2023120101463943300_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2012.04.012","article-title":"Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"60","author":"Anderson","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2023120101463943300_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/j.ajkd.2016.03.429","article-title":"Race\/ethnicity and cardiovascular outcomes in adults with CKD: findings from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies","volume":"68","author":"Lash","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2023120101463943300_bib20","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/sim.3623","article-title":"The estimation of average hazard ratios by weighted Cox regression","volume":"28","author":"Schemper","year":"2009","journal-title":"Statist Med"},{"key":"2023120101463943300_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/toxins12090590","article-title":"Gu-derived protein-bound uremic toxins","volume":"12","author":"Graboski","year":"2020","journal-title":"Toxins"},{"key":"2023120101463943300_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.ftd.0000179849.42395.11","article-title":"The DDAH-ADMA-NOS pathway","volume":"27","author":"Leiper","year":"2005","journal-title":"Ther Drug Monit"},{"key":"2023120101463943300_bib23","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1074\/jbc.M109.091280","article-title":"Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production","volume":"285","author":"Rodionov","year":"2010","journal-title":"J Biol Chem"},{"key":"2023120101463943300_bib24","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3390\/ijms20153668","article-title":"Asymmetric (ADMA) and symmetric (SDMA) dimethylarginines in chronic kidney disease: a clinical approach","volume":"20","author":"Oliva-Damaso","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023120101463943300_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","article-title":"Cellular ADMA: regulation and action","volume":"60","author":"Teerlink","year":"2009","journal-title":"Pharmacol Res"},{"key":"2023120101463943300_bib26","doi-asserted-by":"crossref","first-page":"F149","DOI":"10.1152\/ajprenal.00045.2012","article-title":"Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency","volume":"303","author":"Ronden","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"2023120101463943300_bib27","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/ndt\/gfg452","article-title":"Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia","volume":"18","author":"Nijveldt","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"2023120101463943300_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00726-019-02725-2","article-title":"Plasma ADMA, urinary ADMA excretion, and late mortality in renal transplant recipients","volume":"51","author":"Said","year":"2019","journal-title":"Amino Acids"},{"key":"2023120101463943300_bib29","doi-asserted-by":"crossref","first-page":"e0165811","DOI":"10.1371\/journal.pone.0165811","article-title":"Assymetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies","volume":"11","author":"Shlesinger","year":"2016","journal-title":"PLoS One"},{"key":"2023120101463943300_bib30","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2215\/CJN.11291210","article-title":"Inflammation and asymmetric dimetylarginine for predicting death and cardiovascular events in ESRD patients","volume":"6","author":"Tripepi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023120101463943300_bib31","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2215\/CJN.06671208","article-title":"Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease","volume":"4","author":"Young","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023120101463943300_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1139\/o06-146","article-title":"The inhibitory effect of simvastatin on the ADMA-induced inflammatory reaction is mediated by MAPK pathways in endothelial cells","volume":"85","author":"Jiang","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"2023120101463943300_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/toxins13020142","article-title":"Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets","volume":"13","author":"Lim","year":"2021","journal-title":"Toxins"},{"key":"2023120101463943300_bib34","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"key":"2023120101463943300_bib35","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.kint.2016.01.014","article-title":"Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events","volume":"89","author":"Kim","year":"2016","journal-title":"Kidney Int"},{"key":"2023120101463943300_bib36","doi-asserted-by":"crossref","first-page":"828343","DOI":"10.3389\/fmed.2022.828343","article-title":"Circulating trimethylamine-N-oxide and risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"9","author":"Zhou","year":"2022","journal-title":"Front Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfad103\/50847945\/gfad103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/12\/2809\/53959597\/gfad103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/38\/12\/2809\/53959597\/gfad103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T01:47:45Z","timestamp":1701395265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/38\/12\/2809\/7180011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,5,25]]},"published-print":{"date-parts":[[2023,11,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfad103","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,5,25]]}}}